Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial

Association of Nocturnal Melatonin Secretion With Insulin Resistance in Nondiabetic Young Women

(2013) C. J. McMullan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Melatonin Secretion and the Incidence of Type 2 Diabetes

(2013) Ciaran J. McMullan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes

(2012) Amélie Bonnefond et al.   NATURE GENETICS

Daily Rhythms of Plasma Melatonin, but Not Plasma Leptin or Leptin mRNA, Vary between Lean, Obese and Type 2 Diabetic Men

(2012) Simone Mäntele et al.   PLoS One

Rotating night shift work and disparate hypertension risk in African–Americans

(2011) Sung J. Lieu et al.   JOURNAL OF HYPERTENSION

Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999-2006

(2010) A. Mozumdar et al.   DIABETES CARE

Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats

(2010) María J. Ríos-Lugo et al.   JOURNAL OF PINEAL RESEARCH

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome

(2010) Marzena Koziróg et al.   JOURNAL OF PINEAL RESEARCH

Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels

(2008) Hiroshi Tamura et al.   JOURNAL OF PINEAL RESEARCH

Variants in MTNR1B influence fasting glucose levels

(2008) Inga Prokopenko et al.   NATURE GENETICS

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

(2008) Nabila Bouatia-Naji et al.   NATURE GENETICS